Aspirin Continuation or Interruption in Patients at Moderate Risk for Cardiovascular Events Undergoing Colonoscopy and/or Polypectomy
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2514 participants.
Also called NCT07052799
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 2,514 participants
- Registry
-
NCT07052799
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Hong Kong SAR China
- Registry status
- Recruiting
Technical summary
Registry record NCT07052799. Randomized; quadruple masking; primary purpose prevention. Start 2026-02-10 (actual); primary completion 2030-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Aspirin Continuation or Interruption in Patients at Moderate Risk for Cardiovascular Events Undergoing Colonoscopy and/or Polypectomy
- Condition
- Myocardial Infarction (MI)
- Condition
- Cardiovascular Events
- Condition
- Post Polypectomy Bleeding in Antiplatelet Patients
- Intervention (Drug)
- Aspirin 80mg
- Intervention (Drug)
- Placebo Oral Tablet
- Lead sponsor
- Chinese University of Hong Kong
Record details
- Record id
cardio:ct-nct07052799- Content hash
b6ecf98a49a10d4f80b87592a8be44719a6950b0b5abaaf3021d797fdd6ed91d